Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Thea Vestergaard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Premature Birth, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Aase og Ejnar Danielsens Fond.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Corticosteroids, thiopurines, and biologics may come into play during pregnancy in women with inflammatory bowel disease and potentially impact the developing fetal immune system. We aimed to assess the risk of serious infections in children stratified by in utero exposure to biologics and immunomodulators or concomitant treatment with corticosteroids.
Methods
All singleton IBD pregnancies between 2008 and 2022 at a tertiary IBD center in Denmark were included. Maternal and offspring demographics, maternal disease activity, antenatal medical treatment, and infant infections resulting in hospital admission were recorded after review of medical records.
Results
In 602 live births (99.0%), we registered exposure to antenatal treatment as follows: biological monotherapy (n = 61, 10.2%), thiopurines (n = 110, 17.9%), biologics and concomitant thiopurines (n = 63, 10.3%), and controls (ie, no treatment with biological and/or thiopurines; n = 369, 60.6%). Preterm delivery (<37 gestational weeks) and systemic steroid administration during the third trimester were associated with an increased risk of serious infection in the offspring immediately after birth (relative risk = 17.5; 95% confidence interval, 7.8-39.8; P < .001, and relative risk = 4.8; 95% confidence interval, 1.5-12.7; P = 0.003, respectively). Intra-uterine exposure to biologics or combination treatment were not associated with a statistically significant higher risk of serious infections compared with controls; however, combination treatment showed an inclination towards an increased risk across analyses.
Conclusion
Preterm birth and systemic corticosteroid administration late in pregnancy are significant risk factors for serious infections in the offspring of IBD mothers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Center for Molecular Prediction of Inflammatory Bowel Disease [PREDICT], Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
- Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
- Tufts University School of Medicine, Division of Gastroenterology and Hepatology, Tufts Medical School, Boston, MA, USA.
ORCID-Profile: Thea Vestergaard, Mette Julsgaard
Förderung
- Aase og Ejnar Danielsens Fond
Zitieren
APA
Vestergaard, T., Holm Meiltoft, I., Julsgaard, M., Bek Helmig, R., Friedman, S., & Kelsen, J. (2024). Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad316
Vancouver
Vestergaard T, Holm Meiltoft I, Julsgaard M, Bek Helmig R, Friedman S, Kelsen J. Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad316
BibTeX
@article{Vestergaard2024,
author = {Vestergaard, Thea and Holm Meiltoft, Ida and Julsgaard, Mette and Bek Helmig, Rikke and Friedman, Sonia and Kelsen, Jens},
title = {Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad316}
}
EUVIMED